The Firm

Story and History

Since its founding in 1995, Faruqi & Faruqi has served as lead or co-lead counsel in numerous high-profile cases which ultimately provided significant recoveries to investors, consumers and employees.

Values and Philosophy

Value is a core part of our firm’s professional philosophy. We strive everyday to provide quality legal representation to our clients. This value driven approach is what you should expect from the law firm you select to handle your case. We demand that every member of our team deliver this value day in and day out.

Mission and Services

Faruqi & Faruqi, LLP is here to help our clients by providing them with a high degree of excellence in legal counsel.

Court Praises

Prior Case Disclaimer

The information contained in the Faruqi & Faruqi, LLP (“Faruqi & Faruqi” or the “firm”) Web site is provided for informational purposes only, and should not be construed as legal advice on any subject matter.

No recipients of content from this site, client or otherwise, should act or refrain from acting on the basis of any content included in the site without seeking the appropriate legal or professional advice on the particular facts and circumstances at issue from an attorney licensed in the recipient’s state. The content of this Web site contains general information and may not reflect current legal developments, verdicts or settlements. Faruqi & Faruqi expressly disclaims all liability in respect to actions taken or not taken based on any or all the contents of this site.

If you are interested in viewing information about Faruqi & Faruqi’s past results, please read and acknowledge the information below. The information in this section contains information about the firm’s past results, and may contain testimonials and statements regarding the firm’s quality. This information has not been reviewed or approved by the Florida Bar.

You should know the following:

1. The facts and circumstances of your case may differ from the matters in which results and testimonials have been provided;
2. All results of cases handled by the firm are not provided;
3. And the results provided are not necessarily representative of results obtained by the firm or of the experience of all clients or others with the firm.

Commitment to Diversity

Faruqi & Faruqi, LLP is committed to equal employment opportunities.  We are a firm founded by minorities and will not discriminate against employees or applicants for employment on any legally-recognized basis including, but not limited to: veteran status, uniform servicemember status, race, color, religion, sex, national origin, age, physical or mental disability, genetic information or any other protected class under the federal, state or local laws.  Faruqi & Faruqi, LLP is also committed to providing equal employment opportunities to qualified individuals with disabilities. Faruqi & Faruqi, LLP is certified as a Women’s Business Enterprise (WBE) through the Women’s Business Enterprise National Council (WBENC), the nation’s largest third party certifier of businesses owned and operated by women in the US.

We strive to create the best possible climate for maximum development and goal achievement for all employees. Our practice is to treat each employee as an individual.  We seek to develop a spirit of teamwork; individuals working together to attain a common goal.  In order to maintain an atmosphere where these goals can be accomplished, we provide a comfortable and progressive workplace.  Most importantly, we have a workplace where communication is open and problems can be discussed and resolved in a mutually respectful atmosphere.

Stay up-to-date

Latest Postings from Our Offices

Investigations
Cases
News
Blog
6 Aug 2026
ARS Pharmaceuticals Inc.
Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In ARS Pharmaceuticals To Contact Him Directly To Discuss Their Options If you purchased or acquired securities in ARS Pharmaceuticals between March 9, 2026 and June 24, 2026 and would like to discuss your legal rights, call Faruqi & Faruqi partner Josh Wilson directly at 877-247-4292 or 212-983-9330 (Ext. 1310). Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against ARS Pharmaceuticals Inc. (“ARS Pharmaceuticals” or the “Company”) (NASDAQ: SPRY) and reminds investors of the October 05, 2026 deadline to seek the role of lead plaintiff in a federal securities class action that has been filed against the Company. As detailed below, the complaint alleges that the Company and its executives violated federal securities laws by making false and/or misleading statements and/or failing to disclose that: Defendants provided overwhelmingly positive statements to investors while, at the same time, disseminating false and misleading statements and/or concealing material adverse facts concerning the expected timeline for the expanded insurance coverage for neffy through CVS Caremark. This caused Plaintiff and other shareholders to purchase ARS’s securities at artificially inflated prices. Lead Plaintiff Deadline: October 05, 2026  Call Partner Josh Wilson at 877-247-4292 or 212-983-9330 (Ext. 1310). Or submit your information below to learn about your rights.
James M. Wilson, Jr.
Robert W. Killorin
Lead Plaintiff Deadline
58 Days
Take Action
5 Aug 2026
Alarum Technologies Ltd.
Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In Alarum To Contact Him Directly To Discuss Their Options If you purchased or acquired securities in Alarum between March 20, 2025 and July 2, 2026 and would like to discuss your legal rights, call Faruqi & Faruqi partner Josh Wilson directly at 877-247-4292 or 212-983-9330 (Ext. 1310). Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against Alarum Technologies Ltd. (“Alarum” or the “Company”) (NASDAQ: ALAR) and reminds investors of the October 5, 2026 deadline to seek the role of lead plaintiff in a federal securities class action that has been filed against the Company. As detailed below, the complaint alleges that the Company and its executives violated federal securities laws by making false and/or misleading statements and/or failing to disclose that: (1) An Alarum Technologies subsidiary, NetNut, was engaging in illegal activity by linking customer home internet devices into another network without the customer’s consent; (2) This activity allows cyber criminals to conceal their locations; (3) The foregoing materially heightened Alarum Technologies’ legal exposure and materially threatened its business prospects; and (4) As a result, defendants’ statements about Alarum Technologies’ business, operations, and prospects were materially false and misleading and/or lacked a reasonable basis at all relevant times. Lead Plaintiff Deadline: October 5, 2026  Call Partner Josh Wilson at 877-247-4292 or 212-983-9330 (Ext. 1310) Or submit your information below to learn about your rights.
James M. Wilson, Jr.
Robert W. Killorin
Lead Plaintiff Deadline
58 Days
Take Action
10 Jun 2026
BlackRock TCP Capital Corp
The BlackRock TCP Capital complaint filed in this class action alleges that throughout the Class Period, Defendants made materially false and/or misleading statements, as well as failed to disclose material adverse facts about the Company’s business, operations, and prospects. Specifically, Defendants failed to disclose to investors: (1) the Company’s investments were not being timely and/or appropriately valued; (2) the Company’s efforts at portfolio restructuring were not effectively resolving challenged credits or improving the quality of the portfolio; (3) as a result, the Company’s unrealized losses were understated; (4) as a result, the Company’s NAV was overstated; and (5) that, as a result of the foregoing, Defendants’ positive statements about the Company’s business, operations, and prospects were materially misleading and/or lacked a reasonable basis. For further inquiries regarding this matter, please contact James M. Wilson, Jr. at jwilson@faruqilaw.com or (212) 983-9330. The court-appointed lead plaintiff is the investor with the largest financial interest in the relief sought by the class who is adequate and typical of class members who directs and oversees the litigation on behalf of the putative class. Any member of the putative class may move the Court to serve as lead plaintiff through counsel of their choice, or may choose to do nothing and remain an absent class member. Your ability to share in any recovery is not affected by the decision to serve as a lead plaintiff or not.
James M. Wilson, Jr.
Robert W. Killorin
Read More
4 Jun 2026
Alight, Inc.
The Alight, Inc. class action law suit alleges that the Company and its executives violated federal securities laws by making false and/or misleading statements and/or failing to disclose the true state of Alight’s growth potential and financial stability; notably, that the Company was not truly equipped to execute on its claimed potential and could not maintain its promised dividend as a result. Rather, Alight would require significantly higher compensation and incentive expenses to achieve the projections put forth by management. Throughout the class period, Defendants announced disappointing results, reduced projections, and multiple goodwill impairments all while remaining confident in their ability to execute, drive growth, and continue to provide a dividend to their shareholders. For further inquiries regarding this matter, please contact James M. Wilson, Jr. at jwilson@faruqilaw.com or (212) 983-9330. The court-appointed lead plaintiff is the investor with the largest financial interest in the relief sought by the class who is adequate and typical of class members who directs and oversees the litigation on behalf of the putative class. Any member of the putative class may move the Court to serve as lead plaintiff through counsel of their choice, or may choose to do nothing and remain an absent class member. Your ability to share in any recovery is not affected by the decision to serve as a lead plaintiff or not.
James M. Wilson, Jr.
Robert W. Killorin
Read More
10 Jun 2026
Faruqi & Faruqi Appointed Sole Lead Counsel to Represent BlackRock TCP Capital Corp. Shareholders in Securities Class Action
Read More
4 Jun 2026
Faruqi & Faruqi Appointed Sole Lead Counsel to Represent Alight, Inc. Shareholders in Securities Class Action
Read More
5 Aug 2026
New York Legislature Passes Anti-Waiver of Employment Rights Act
Read More
3 Aug 2026
The Supreme Court’s Sports Decision Isn’t the End of the Story for Transgender Rights
Read More

Our Offices

Our offices are nationwide. If you have any questions about a case or our firm, please contact us.
Send Us a Message
New York
685 Third Avenue 26th Floor
New York New York 10017
(877) 247-4292 / (212) 983-9330
(212) 983-9331
Los Angeles
1901 Avenue of the Stars Suite 1060
Los Angeles California 90067
(424) 256-2884
(424) 256-2885
Atlanta
3565 Piedmont Road NE Building Four, Suite 380
Atlanta Georgia 30305
(404) 847-0617
(404) 506-9534
Philadelphia
1617 JFK Boulevard, Suite 1550 Philadelphia
Pennsylvania 19103
(215) 277-5770
(215) 277-5771